In a new systematic review in JAMA Neurology, Michigan Medicine researchers found reason to further explore the surprising effects of zolpidem that have been observed outside the scope of its primary Food and Drug Administration approval.
from Dementia Big http://ift.tt/2scmIff via alcoholic dementia
http://ift.tt/2sN7EmQ
No comments:
Post a Comment